Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 25:13:1756286420949808.
doi: 10.1177/1756286420949808. eCollection 2020.

Gender issues of antibody-mediated diseases in neurology: (NMOSD/autoimmune encephalitis/MG)

Affiliations
Review

Gender issues of antibody-mediated diseases in neurology: (NMOSD/autoimmune encephalitis/MG)

Ayse Altintas et al. Ther Adv Neurol Disord. .

Abstract

Neuromyelitis optica spectrum disorder (NMOSD), autoimmune encephalitis (AE), myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) are antibody-mediated neurological diseases. They have mostly female predominance, affecting many women during childbearing age. Interactions between the underlying disease (or necessary treatment) and pregnancy can occur in every of these illnesses. Herein, we present the characteristics of NMOSD, AE, MG and LEMS in general, and review published data regarding the influence of the different diseases on fertility, pregnancy, puerperium, treatment strategy during pregnancy and post-partum period, and menopause but also male factors. We summarise key elements that should be borne in mind when confronted with such cases.

Keywords: Lambert-Eaton myasthenic syndrome; autoimmune encephalitis; myasthenia gravis; neuromyelitis optica spectrum disease; pregnancy; sex differences; women.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: Ayse Altintas has received speaker honoraria for non-promotional education events and travel grants from Merck, TEVA and Novartis. Christiane Schneider-Gold has received consulting and speaker’s honoraria from Alexion Pharmaceuticals, Amicus Therapeutics, Bayer Schering, CSL Behring, Grünenthal, Lupin Pharmaceuticals and TEVA. Andrea I. Ciplea has received speaker honoraria from Bayer Healthcare and travel grants from Sanofi Genzyme, Teva and Novartis. Frank Leypoldt discloses receiving speaker honoraria from Biogen, Roche, Merck, Fresenius, Teva, Bayer, Novartis, Alexion and advisory board memberships Roche, Biogen and Alexion. Kerstin Hellwig has received travel grants from Biogen, Novartis and Merck; received speaker and research honoraria from Biogen Idec Germany, Teva, Sanofi Genzyme, Novartis, Bayer Healthcare, Merck Serono and Roche. Frank Leypoldt, Klaus-Peter Wandinger, Justina Dargvainiene and Ralf Junker disclose working for an academic institution offering commercial antibody testing.

References

    1. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106–2112. - PubMed
    1. Pittock SJ, Lucchinetti CF. Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later. Ann N Y Acad Sci 2016; 1366: 20–39. - PMC - PubMed
    1. Jarius S, Franciotta D, Paul F, et al. Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation 2010; 7: 52. - PMC - PubMed
    1. Waters PJ, McKeon A, Leite MI, et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4 IgG assays. Neurology 2012; 78: 665–671; discussion 669. - PMC - PubMed
    1. Reindl M, Di Pauli F, Rostásy K, et al. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 2013; 9: 455–461. - PubMed

LinkOut - more resources